| 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society |
77 |
| 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy |
68 |
| 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society |
60 |
| 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society |
54 |
| A beginner's guide to permanent left bundle branch pacing |
48 |
| Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablations |
47 |
| Permanent His bundle pacing: Recommendations from a Multicenter His Bundle Pacing Collaborative Working Group for standardization of definitions, implant measurements, and follow-up |
46 |
| Prospective evaluation of feasibility and electrophysiologic and echocardiographic characteristics of left bundle branch area pacing |
44 |
| Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: A multicenter experience |
41 |
| Permanent left bundle branch area pacing for atrioventricular block: Feasibility, safety, and acute effect |
32 |
| Permanent His-bundle pacing: Long-term lead performance and clinical outcomes |
30 |
| 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary |
28 |
| Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices |
28 |
| Arrhythmias in myocarditis: State of the art |
28 |
| Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control |
27 |
| Left bundle branch pacing for symptomatic bradycardia: Implant success rate, safety, and pacing characteristics |
26 |
| Posterior wall isolation using the cryoballoon in conjunction with pulmonary vein ablation is superior to pulmonary vein isolation alone in patients with persistent atrial fibrillation: A multicenter experience |
24 |
| Intracardiac pulsed field ablation: Proof of feasibility in a chronic porcine model |
23 |
| Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block |
22 |
| On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial |
21 |
| Assessing the accuracy of an automated atrial fibrillation detection algorithm using smartphone technology: The iREAD Study |
20 |
| Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies |
18 |
| Association of fibrotic remodeling and cytokines/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation |
18 |
| Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator |
17 |
| Electrical isolation of the left atrial appendage increases the risk of ischemic stroke and transient ischemic attack regardless of postisolation flow velocity |
17 |
| Outcomes of rescue cardiopulmonary support for periprocedural acute hemodynamic decompensation in patients undergoing catheter ablation of electrical storm |
16 |
| Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results |
16 |
| Revisiting anatomic macroreentrant tachycardia after atrial fibrillation ablation using ultrahigh-resolution mapping: Implications for ablation |
16 |
| Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: Clinical outcomes from the real-world multicenter observational project |
16 |
| Contact force sensing for ablation of persistent atrial fibrillation: A randomized, multicenter trial |
15 |
| Performance and limitations of noninvasive cardiac activation mapping |
15 |
| Ventricular arrhythmias and sudden cardiac arrest in Takotsubo cardiomyopathy: Incidence, predictive factors, and clinical implications |
14 |
| A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score |
13 |
| Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review |
13 |
| Effect of bipolar electrode orientation on local electrogram properties |
13 |
| The pathophysiology of the vasovagal response |
13 |
| Right anterior ganglionated plexus: The primary target of cardioneuroablation? |
13 |
| Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: Experience from the real world |
13 |
| Cryoballoon Best Practices II: Practical guide to procedural monitoring and dosing during atrial fibrillation ablation from the perspective of experienced users |
13 |
| Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome |
13 |
| The role of Marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation |
12 |
| Ibrutinib promotes atrial fibrillation by inducing structural remodeling and calcium dysregulation in the atrium |
12 |
| Feasibility, safety, and efficacy of a novel preshaped nitinol esophageal deviator to successfully deflect the esophagus and ablate left atrium without esophageal temperature rise during atrial fibrillation ablation: The DEFLECT GUT study |
12 |
| Atrial fibrillation and cognitive decline in the Framingham Heart Study |
11 |
| Moderate alcohol consumption is associated with atrial electrical and structural changes: Insights from high-density left atrial electroanatomic mapping |
11 |
| Electrogram signature of specific activation patterns: Analysis of atrial tachycardias at high-density endocardial mapping |
11 |
| Epicardial connection between the right-sided pulmonary venous carina and the right atrium in patients with atrial fibrillation: A possible mechanism for preclusion of pulmonary vein isolation without carina ablation |
11 |
| Beneficial effects of upgrading to His bundle pacing in chronically paced patients with left ventricular ejection fraction < 50% |
11 |
| Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: A viable solution? |
11 |
| Endoscopic evaluation of the esophagus after catheter ablation of atrial fibrillation using contiguous and optimized radiofrequency applications |
10 |
